Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rhinology ; 60(6): 479-480, 2022 Dec 01.
Article in English | MEDLINE | ID: mdl-36150157

ABSTRACT

Nasal disorders and cardiovascular damage: flow-mediated dilation and intima-media thickness as risk parameters.


Subject(s)
Carotid Intima-Media Thickness , Nose Diseases , Humans , Dilatation , Risk Factors
2.
Crit Rev Oncol Hematol ; 165: 103432, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34352361

ABSTRACT

BACKGROUND: Moderately hypofractionated radiotherapy (RT) currently represents the standard RT approach for all prostate cancer (PCa) risk categories. We performed a systematic review and meta-analysis of available literature, focusing on acute and late genitourinary (GU) and gastrointestinal (GI) adverse events (AEs) of moderate hypofractionation for localized PCa. MATERIALS AND METHODS: Literature search was performed and two independent reviewers selected the records according to the following Population (P) Intervention (I) Comparator (C) and Outcomes (O) (PICO) question: "In patients affected by localized PCa (P), moderately hypofractionated RT (defined as a treatment schedule providing a single dose per fraction of 3-4.5 Gy) (I) can be considered equivalent to conventionally fractionated RT (C) in terms of G > 2 GI and GU acute and late adverse events (O)?". Bias assessment was performed using Cochrane Cochrane Collaboration's Tool for Assessing Risk of Bias. RESULTS: Thirteen records were identified and a meta-analysis was performed. Risk of acute GI and GU > 2 adverse events in the moderately hypofractionated arm was increased by 9.8 % (95 %CI 4.8 %-14.7 %; I2 = 57 %) and 1.5 % (95 % CI -1.5 %-4.4 %; I2 = 0%), respectively. DISCUSSION: Overall, majority of trials included in our meta-analysis suggested that moderately hypofractionated RT is equivalent, in terms of GI and GU adverse events, to conventional fractionation. Pooled analysis showed a trend to increased GI toxicity after hypofractionated treatment, but this might be related to dose escalation rather than hypofractionation.


Subject(s)
Gastrointestinal Diseases , Prostatic Neoplasms , Radiotherapy, Intensity-Modulated , Dose Fractionation, Radiation , Humans , Male , Prostatic Neoplasms/radiotherapy , Radiation Dose Hypofractionation
3.
Jpn J Radiol ; 39(12): 1223-1228, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34241797

ABSTRACT

OBJECT: To analyze geometrical approaches, prescription modalities, and delivery efficiency for linear accelerator (Linac)-based STereotactic Arrhythmia Radioablation (STAR) for ventricular tachycardia. METHODS: The anatomy and planning target volume (PTV) of the first Italian STAR patient were used. To assess geometrical approaches, 3 plans prescribed to 75% isodose-line, differing for number, length of arcs, and couch rotations, were generated and compared (Plans#1-3). Volumetric-arc with 6-MV flattening-filter-free (FFF) was employed. To evaluate prescription modality and delivery, the best geometrical plan was compared with other plans prescribed on 70%, 65%, and 60% isodose-line and with another one using 10MV-FFF beams (Plans#4-7). RESULTS: For Plans#1-3, PTV coverage, mean cardiac dose, monitor units (MUs), and beam-delivery-time (BDT) were 96-98.5%, 4.9-5.2 Gy, 7047-7790, and 5-6 min, respectively. Plans#4-7 were similar in terms of mean cardiac dose, MUs and BDT to Plans#1-3, except in maximum dose and lower time for 10MV-FFF plan. CONCLUSION: Linac-based STAR is safe and efficient in terms of BDT and MUs. To ensure high dose to PTV, different dose prescription modalities should be evaluated. The 10FFF approach was the faster but not suitable in patient with cardiac implantable electronic devices.


Subject(s)
Radiosurgery , Radiotherapy, Intensity-Modulated , Tachycardia, Ventricular , Arrhythmias, Cardiac , Humans , Particle Accelerators , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted
4.
Biomed Res Int ; 2018: 9032408, 2018.
Article in English | MEDLINE | ID: mdl-30140703

ABSTRACT

Breast cancer is the main cause of female malignancy worldwide. Effective early detection by imaging studies remains critical to decrease mortality rates, particularly in women at high risk for developing breast cancer. Breast Magnetic Resonance Imaging (MRI) is a common diagnostic tool in the management of breast diseases, especially for high-risk women. However, during this examination, both normal and abnormal breast tissues enhance after contrast material administration. Specifically, the normal breast tissue enhancement is known as background parenchymal enhancement: it may represent breast activity and depends on several factors, varying in degree and distribution in different patients as well as in the same patient over time. While a light degree of normal breast tissue enhancement generally causes no interpretative difficulties, a higher degree may cause difficulty to detect and classify breast lesions at Magnetic Resonance Imaging even for experienced radiologists. In this work, we intend to investigate the exploitation of some statistical measurements to automatically characterize the enhancement trend of the whole breast area in both normal and abnormal tissues independently from the presence of a background parenchymal enhancement thus to provide a diagnostic support tool for radiologists in the MRI analysis.


Subject(s)
Breast Neoplasms/diagnostic imaging , Magnetic Resonance Imaging , Adult , Aged , Contrast Media , Female , Humans , Image Enhancement , Middle Aged , Retrospective Studies , Young Adult
5.
Gastrointest Endosc ; 51(6): 772, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10840330
SELECTION OF CITATIONS
SEARCH DETAIL
...